GRAND YANGTZE CAPITAL
Grand Yangtze Capital is an investment firm focused principally on equity investments in growth and expansion stage enterprises in China. They have been managing 7 PE and VC funds since 2007 and have deployed over 4 billion RMB. Grand Yangtze Capital has invested in over 40 companies, among which 8 companies went public, and several others were merged or acquired, e.g. Sino-Crystal (300064), Shuanghuan(002472), Hainan Rubber(601118), HLBN(300291), ZMJ(601717), China UMS, ZBT Pharma, ELLASSAY(603808), B-Soft(300451), Guochuang Software(300520), YMatou, Pharma Block, etc.
GRAND YANGTZE CAPITAL
Industry:
Financial Services
Founded:
2006-01-01
Status:
Active
Contact:
86-21-60475959
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Mobile Non Scaleable Content Nginx Euro Apple Mobile Web App Capable DigiCert SSL Pound Sterling Apple Mobile Web App Status Bar Style
Similar Organizations
China Venture Capital HRVC
China Venture Capital HRVC is a professional private equity investment management organization that offers consulting.
CPP Investment Board Europe
CPP Investment Board Europe is a professional investment management organization.
Dreamfly Capital
Dreamfly Capital is a professional asset management organization.
Fosun Capital
Fosun Capital is an equity investment management company.
Guofang Capital
Guofang Capital is a professional market-based equity investment platform with an asset under management.
Kaitai Capital
Kaitai Capital is a professional investment management organization.
Peak Valley Capital
Peak Valley Capital is a professional equity investment organization.
Shanghai SIIC Fund Management
Shanghai SIIC Fund Management is a professional equity investment fund management platform.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-06 | YunLSP | Grand Yangtze Capital investment in Series B - YunLSP | 100 M CNY |
| 2022-03-29 | Yaotan Pharmaceutical | Grand Yangtze Capital investment in Series A - Yaotan Pharmaceutical | 200 M CNY |
| 2021-11-29 | Vision Semiconductor Technology | Grand Yangtze Capital investment in Series A - Vision Semiconductor Technology | 100 M CNY |
| 2021-03-10 | Aucta Pharmaceuticals China | Grand Yangtze Capital investment in Series A - Aucta Pharmaceuticals China | N/A |
| 2020-09-04 | InxMed | Grand Yangtze Capital investment in Series A - InxMed | 130 M CNY |
| 2020-03-06 | CRP Robot | Grand Yangtze Capital investment in Series B - CRP Robot | 14.4 M USD |
| 2019-12-18 | Tongtongeyan | Grand Yangtze Capital investment in Venture Round - Tongtongeyan | 50 M CNY |
| 2019-12-14 | Licai Mofang | Grand Yangtze Capital investment in Series A - Licai Mofang | 77 M CNY |
| 2019-09-11 | Stroke Medical | Grand Yangtze Capital investment in Series B - Stroke Medical | 100 M CNY |
| 2019-05-09 | Raise3D | Grand Yangtze Capital investment in Series B - Raise3D | N/A |